ImportRefusal LogoImportRefusal

Bausch Health Companies Inc.

⚠️ High Risk

FEI: 3002806613 • Steinbach, Manitoba • CANADA

FEI

FEI Number

3002806613

📍

Location

Steinbach, Manitoba

🇨🇦

Country

CANADA
🏢

Address

100 Life Sciences Pky, Box 21390, Steinbach, Manitoba, Canada

High Risk

FDA Import Risk Assessment

54.0
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

9
Total Refusals
2
Unique Violations
2/7/2023
Latest Refusal
11/1/2001
Earliest Refusal

Score Breakdown

Violation Severity
85.6×40%
Refusal Volume
37.0×30%
Recency
41.3×20%
Frequency
4.2×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

757×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

162×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

Refusal History

DateProductViolationsDivision
2/7/2023
66VDY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/20/2022
61NCA05BUPROPION HCL (ANTI-DEPRESSANT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
4/13/2018
61NCB05BUPROPION HCL (ANTI-DEPRESSANT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/23/2017
61NCA05BUPROPION HCL (ANTI-DEPRESSANT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/14/2015
66VBF99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
New York District Office (NYK-DO)
3/17/2005
62VDO18ACYCLOVIR (ANTI-VIRAL)
75UNAPPROVED
Florida District Office (FLA-DO)
10/17/2002
60LIC69TRAMADOL HCL (ANALGESIC)
75UNAPPROVED
New Orleans District Office (NOL-DO)
12/19/2001
55RP14HYDROXYPROPYL METHYLCELLULOSE (PHARMACEUTIC NECESSITY - SUSPENDING AGENT)
16DIRECTIONS
New Orleans District Office (NOL-DO)
11/1/2001
66VIE99MISCELLANEOUS PATENT MEDICINES, ETC.
16DIRECTIONS
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Bausch Health Companies Inc.'s FDA import refusal history?

Bausch Health Companies Inc. (FEI: 3002806613) has 9 FDA import refusal record(s) in our database, spanning from 11/1/2001 to 2/7/2023.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Bausch Health Companies Inc.'s FEI number is 3002806613.

What types of violations has Bausch Health Companies Inc. received?

Bausch Health Companies Inc. has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Bausch Health Companies Inc. come from?

All FDA import refusal data for Bausch Health Companies Inc. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.